C34H37FN2O5
Neat
572.68
3-O-Methylatorvastatin; 887324-53-0; UNII-W4O2NOR8VV; W4O2NOR8VV; Atorvastatin calcium trihydrate impurity G [EP]; (3R, 5R)-7-(2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxy-3-methoxyheptanoic acid; DTXSID40237277; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-delta-hydroxy-beta-methoxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (betaR, deltaR)-; 1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-.DELTA.-HYDROXY-.BETA.-METHOXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-, (.BETA.R, .DELTA.R)-; ATORVASTATIN CALCIUM TRIHYDRATE IMPURITY G (EP IMPURITY); ATORVASTATIN CALCIUM TRIHYDRATE IMPURITY G [EP IMPURITY]; RefChem:95164; DTXCID40159768; Atorvastatin calcium trihydrate impurity G; Atorvastatin EP Impurity G; (3R, 5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxy-3-methoxyheptanoic acid; Atorvastatin Impurity G; (3R, 5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxy-3-methoxyheptanoicacid; (3R and 5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-5-hydroxy-3-methoxyheptanoic acid; SCHEMBL12285672
(3R and 5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-5-hydroxy-3-methoxyheptanoic acid
InChI=1S/C34H37FN2O5/c1-22(2)32-31(34(41)36-26-12-8-5-9-13-26)30(23-10-6-4-7-11-23)33(24-14-16-25(35)17-15-24)37(32)19-18-27(38)20-28(42-3)21-29(39)40/h4-17,22,27-28,38H,18-21H2,1-3H3,(H,36,41)(H,39,40)/t27-,28-/m1/s1